1. Home
  2. SLI vs PRME Comparison

SLI vs PRME Comparison

Compare SLI & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standard Lithium Ltd.

SLI

Standard Lithium Ltd.

HOLD

Current Price

$1.45

Market Cap

524.3M

Sector

Industrials

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.63

Market Cap

526.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLI
PRME
Founded
1998
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
524.3M
526.0M
IPO Year
2011
2022

Fundamental Metrics

Financial Performance
Metric
SLI
PRME
Price
$1.45
$3.63
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$4.49
★ $7.11
AVG Volume (30 Days)
2.1M
★ 4.6M
Earning Date
08-10-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.18
EPS
★ N/A
N/A
Revenue
N/A
★ $4,632,000.00
Revenue This Year
N/A
$90.65
Revenue Next Year
N/A
$19.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 55.28
52 Week Low
$1.32
$2.67
52 Week High
$6.00
$5.20

Technical Indicators

Market Signals
Indicator
SLI
PRME
Relative Strength Index (RSI) 28.27 52.72
Support Level $1.32 $2.89
Resistance Level $2.25 $3.69
Average True Range (ATR) 0.08 0.39
MACD 0.02 0.03
Stochastic Oscillator 30.49 52.97

Price Performance

Historical Comparison
SLI
PRME

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company's flagship projects are located in the Smackover Formation, a world-class lithium brine asset, focused in Arkansas and Texas. It is also Standard Lithium is advancing the South West Arkansas project, a greenfield project located in southern Arkansas, and strengthening lithium brine prospects in East Texas. Its other project comprises the Lanxess Property Project; and California Properties. The technologies used for the projects are : Direct Lithium Extraction; Demonstration Plant; SiFT; Lithium Sulfide; and Aqualung.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: